Alfathesin ('Althesin' - Glaxo): an independent report.
D000014:Abnormalities, Drug-Induced / Q000209:etiology; D000698:Analgesia; D000766:Anesthesia, Dental; D000771:Anesthesia, Intravenous; D000773:Anesthesia, Obstetrical; D000777:Anesthetics / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology; D000818:Animals; D002415:Cats; D004338:Drug Combinations; D004565:Electroconvulsive Therapy; D004569:Electroencephalography; D005260:Female; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D006914:Hydroxysteroids; D007427:Intracranial Pressure / Q000187:drug effects; D007700:Kinetics; D051379:Mice; D009132:Muscles / Q000187:drug effects; D013508:Ophthalmologic Surgical Procedures; D011247:Pregnancy; D011277:Pregnanediones / Q000494:pharmacology; D011485:Protein Binding; D011817:Rabbits; D012119:Respiration / Q000187:drug effects; D013874:Thiopental; D014680:Veins / Q000187:drug effects
D000777:Anesthetics; D004338:Drug Combinations; D006914:Hydroxysteroids; D011277:Pregnanediones; D013874:Thiopental